Biobanking is an emerging specialty in which competencies in cellular and molecular biology, medicine, genetics, cryobiology, bioengineering, information technology and ethics merge into a service aimed at the regular collection, characterization, long-term storage and distribution -mostly at subzero temperatures -of a large set of biological materials. Among the possible different modalities to organize biobanking activities, the operational setting and typical infrastructures of blood centers and clinical pathology laboratories seem to offer significant advantages as compared to other frameworks, with regard to sample traceability, staff qualification, largevolume operation, networking capability. In view of a broader use of biological materials and the expansion of biobanking research, efforts should be developed to harmonize local, regional, national and international regulations, guidelines, norms and laws on biobanking, and to increase the population awareness of the importance of participating in biobanking programs. We propose that the model of the 'Biological Resource Centre' described by the Organization for the Economic Cooperation and Development (OECD) is used as a structural and operational reference for the consolidation of multispeciality biobanking programs.
Introduction
A search in the Pubmed database performed on March 7, 2007 with the terms 'bank', 'blood bank', 'banking', 'biobank or biorepository' and 'biobanking' identified 18,736, 6,076, 2,069, 118, and 16 publications, respectively. Not surprisingly, a progressively decreasing number of publications parallels the evolution from a broad and consolidated term like 'bank', traditionally used and widely applicable to numerous elements of biological processes and medical procedures, to a more recent word like 'biobanking', which combines into one single term multiple specialist activities concerning the collection, characterization, storage, and distribution of a large set of biological materials. The small number of articles associated with the term 'biobanking' suggests that research in this field is still in its infancy. Nonetheless, although numerically limited, the set of articles selected with this basic search describe a vast area of diverse competencies and interests, spanning from biobank management models applicable to biomedical research [1] , to epidemiology of Kaposi's sarcoma [2] , to RNA stability in frozen surgical tissue samples [3] , to ethical issues [4, 5] , technology transfer [6] , accountability [7] . In this article, we review the perspectives of biobanking in 2007, with particular attention to public biobanking programs involved in biomedical research and cellular therapy. Our reference organizational model for the harmonic combination of these activities is that of the Biological Resource Centers proposed by the Organization for the Economic Cooperation and Development (OECD) in 1999 [8, 9] .
Definitions
Biological resources have been defined by the OECD as the composition of living organisms, cells, genes, and the related information [8] . The same organization also provides a definition of Biological Resource Centers (BRC). According to this definition, BRC are 'an essential part of the infrastructure underpinning biotechnology. They consist of service providers and repositories of the living cells, genomes of organisms, and information relating to heredity and the functions of biological systems. BRCs contain collections of culturable organisms (e.g. micro-organisms, plant, animal, and human cells), replicable parts of these (e.g. genomes, plasmids, viruses, cDNAs), viable but not yet culturable organisms, cells and tissues, as well as databases containing molecular, physiological, and structural information relevant to these collections and related bioinformatics. BRC must meet the high standard of quality and expertise demanded by the international community of scientists and industry for the delivery of biological information and materials. They must provide access to biological resources on which R and D in the life sciences and the advancement of biotechnology depends.' [9] .
From the wording of this definition, it is clearly evident that the BRC model is the historical evolution of the classical repository of biological materials, traditionally termed 'biobank'. It should be noted, however, that the current BRC definition puts a particular emphasis not only on the internal activities of the BRC, but also on the need of and opportunity for national and international, actual or virtual networking of biobanking activities through this type of organization.
Different Types of Biobanks
There are different types of biobanks, depending on the biobank mission and objectives (table 1) . For example, there are biobanks entirely devoted to the prospective banking of leftover normal and pathological tissues collected during routine clinical pathology diagnostic procedures ('leftover tissue biobank') [10] . In view of developing a national network, an extensive survey of activities at 12 cancer biorepositories in the USA, aimed at identifying 'best practices' at these institutions, was carried out by RAND Science and Technology, a unit of the RAND corporation. A freely downloadable report of this detailed survey is available at www.rand.org/pubs/ monographs/2004/RAND_MG120.pdf. This report contains valuable information on biobanking costs, and provides an effective methodological approach to the identification of 'best practices' that could be profitably exploited in other settings and other countries. Other biobanks, collectively termed 'genetic biobanks' [11] [12] [13] collect biological samples from the general population ('population biobanks') [14] [15] [16] [17] [18] [19] [20] [21] or from particular subsets of individuals ('twin biobanks') [22, 23] . Other programs specifically aim at developing collections of biological samples from patients suffering from selected conditions ('disease biobank') [24] [25] [26] [27] [28] [29] or from a specific organ ('organ biobank'). Another distinction regards the human versus non-human biological materials (e.g. 'primate biobanks'), or the purpose of expanding the storage services beyond the animal world into the plant domain or into programs related to environment protection ('biodiversity biobank' [30] , 'biomonitoring biobank'). Far from being comprehensive, the previous paragraphs report just a few examples of the numerous types and terms which characterize biobanks. The international experience so far developed supports the choice of networking biobanking activities, with the main purposes of increasing the critical mass and the bio-diversity of stored samples, of standardizing collection, characterization, storage and distribution procedures, of facilitating sample access to investigators, of sharing with the population the results of studies performed with the collected samples, and to optimize the use of the financial, professional and technological resources ( ample is the P 3 G Consortium (www.p3gconsortium.org) which provides in its website the following definition: 'The Public Population Project in Genomics (P 3 G) is an international consortium for the development and management of a multidisciplinary infrastructure for comparing and merging results from population genomic studies. P 3 G will enable the international research community to deliver more effective health care strategies aimed at disease prevention, and at tailoring medicines and other treatment regimens to individuals, families and communities'. An example of a local multinational program, which is part of the P 3 G, is the Danubian Biobank Foundation which involves 6 countries in central Europe. Besides the biobanking initiatives directed at the general population, an interesting biobanking opportunity is offered by settings where selected population groups regularly undergo blood collection for different purposes. Notable examples are blood donation for transfusion purposes (healthy subjects, on average between 2 and 5% of the population), and blood collection for clinical pathology laboratory testing (diseased subjects). Such settings offer the advantage that a 'left-over research blood sample' can be easily and routinely obtained as a by-product of the main procedures for which blood is collected, i.e. avoiding additional recruitment costs. Of course, such biobanking programs require specific informed consent and adequate information technology. Moreover, they need to take into account that blood donors and diseased subjects are selected cohorts, this feature being a specific characteristic rather than a limitation. A recent example of a regular biobanking program involving blood donors which was developed not just for legal matters related to liability of the blood center in case of post-transfusion complications is the 'Biobank der Blutspender' (Blood Donor Biobank) of the Bavarian Red Cross Blood Bank. The purpose of this program is to offer unique resources for biomarker research, i.e. to investigate the prognostic value of known biomarkers or to identify new biomarkers by using blood samples collected before the onset of a certain disease [31] . A technological unifier of all biobanking programs is the cryogenic area which requires a sophisticated integration of liquid nitrogen pipelines, reservoirs and storage tanks, mechanical freezers, information technology [32, 33] , cryobiology skills [34, 35] and safety features suitable to protect operators and preserve the quality of the stored samples [36] [37] [38] [39] . A list of reference norms, laws and regulations that were taken into consideration during the construction of our cryobiology area and which are currently used for maintenance and repair purposes, is shown in table 3. Similar sets of documents and local laws, mostly related to safety assurance for the staff, are used by biobanks which operate in different countries. Because of the need for all biobanks to use high and expensive technology in the cryogenic area and to follow stringent regulations to assure operations safety, it is evident that models integrating different types of biobanks into a unique facility of appropriate size may offer economic and operational advantages [8] . Moreover, the relatively limited availability of specifically trained staff may favor integrated models ('multispecialty biobanks') as opposed to programs limited to one specialist interest. 
Ethical and Biojuridical Issues
Besides the fundamental biological, medical, technological, and administrative skills necessary for an efficient biobank management, issues regarding the compliance of all biobanking procedures with ethical and biojuridical requirements are of utmost importance [16, [40] [41] [42] [43] [44] [45] . In fact, the growing development of biobanking research raises a number of ethical and legal issues related to the involvement of human subjects into the process of biological material donation. As reported in the international literature, the principal issues concern the informed consent of participants in biobanking research, ownership of donated samples, data protection, intellectual property rights. In particular, the definition of an appropriate informed consent model for the storage of human biological materials (such as blood, serum, tissue, DNA, RNA) in view of future research raised a widespread debate at the international, national, and regional levels [46] . What is prevailingly debated is the type of information to be given to a potential donor and the type of consent a research subject should be asked for [47] [48] [49] [50] [51] [52] [53] [54] [55] . Currently, there is no common view on ethical and legal requirements for biobanking research [45, 56] . Accordingly, there are a large number of differences among regulations, laws, recommendations, and policies at the international and national levels. There are also different standards of informed consent for biobanking research. This fragmentation generates confusion in operators involved in technical procedures and uncertainty in the general population [57] [58] [59] [60] [61] [62] [63] [64] . At our institution, we had the chance to deal with these issues and to propose a practical solution to the controversial problem of the informed consent model for biobanking research. In this regard, we developed a method, based on a multidisciplinary work group including several scientists and a jurist, to design a standard informed consent model for the collection, the storage, and the use of human biological materials for known and unplanned research purposes. This model, which was derived from the analysis of 51 medical and surgical procedures performed in our hospital which could yield biological materials, was approved by the competent body of our hospital and has become a formal procedure to store and use human biological materials for research studies. Cornerstones of this recent, as yet unpublished experience, were i) the review of different types of informed consent models published in the literature; ii) the development of an adequate communication model with research subjects; iii) the development of a particular educational program for health operators about information, communication, and consent to store biological materials of human origin for planned and unplanned studies.
The Biological Resource Center of the Foundation 'Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena'
The purpose of this paragraph is to describe our interpretation of the model of the BRC proposed by the OECD, as applied to the local setting of a large university hospital interested in biobanking research. To this aim, we report our mission and briefly describe our main functions. The mission of the BRC of our hospital is to collect, characterize, process, store, and release human and non-human biological materials and their associated data according to national and international standards of excellence. priate to plan harmonic local, regional, national, and international programs to integrate and further develop current procedures to collect, characterize, store, and distribute top quality biological materials through a worldwide network of Biological Resource Centers. Needless to say, the ability to involve the community with effective consulting strategies will be of crucial importance to ensure the success of these programs [65] .
